|
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (October 2013) |
Osteopetrosis (malignant) |
Classification and external resources |
X-ray of the pelvis of a patient with osteopetrosis, adult onset form (Albers-Schönberg disease). Note the dense bones.
|
ICD-10 |
Q78.2 |
ICD-9 |
756.52 |
OMIM |
166600 259700 |
DiseasesDB |
9377 |
eMedicine |
med/1692 |
Patient UK |
Osteopetrosis |
MeSH |
D010022 |
Osteopetrosis, literally "stone bone", also known as marble bone disease and Albers-Schönberg disease, is an extremely rare inherited disorder whereby the bones harden, becoming denser, in contrast to more prevalent conditions like osteoporosis, in which the bones become less dense and more brittle, or osteomalacia, in which the bones soften. Osteopetrosis can cause bones to dissolve and break.[1]
It can cause osteosclerosis.[2] The cause of the disease is understood to be malfunctioning osteoclasts. Radiological findings will show a bone-in-bone appearance.[3]
Contents
- 1 Pathogenesis
- 2 Signs and symptoms
- 3 Variations
- 4 Differential diagnosis
- 5 Treatment
- 6 Notable cases
- 7 See also
- 8 References
- 9 External links
Pathogenesis
Normal bone growth is achieved by a balance between bone formation by osteoblasts and bone resorption (breakdown of bone matrix) by osteoclasts. In osteopetrosis, the number of osteoclasts may be reduced, normal, or increased. Most importantly, osteoclast dysfunction mediates the pathogenesis of this disease.
The exact mechanism is unknown. However, deficiency of carbonic anhydrase in osteoclasts is noted. The absence of this enzyme causes defective hydrogen ion pumping by osteoclasts, and this, in turn, causes defective bone resorption by osteoclasts, as an acidic environment is needed for dissociation of calcium hydroxyapatite from bone matrix. Hence, bone resorption fails while its formation persists. Excessive bone is formed.[4]
Signs and symptoms
A 17-year-old male with osteopetrosis tarda: Typical cranial deformity and thoracic scoliosis
Despite this excess bone formation, people with osteopetrosis tend to have bones that are more brittle than normal. Mild osteopetrosis may cause no symptoms, and present no problems. However, serious forms can result in stunted growth, deformity, and increased likelihood of fractures; also, patients suffer anemia, recurrent infections, and hepatosplenomegaly due to bone expansion leading to bone marrow narrowing and extramedullary hematopoiesis. It can also result in blindness, facial paralysis, and deafness, due to the increased pressure put on the nerves by the extra bone.[5]
Comparison of bone pathology
Condition |
Calcium |
Phosphate |
Alkaline phosphatase |
Parathyroid hormone |
Comments |
Osteoporosis |
unaffected |
unaffected |
normal |
unaffected |
decreased bone mass |
Osteopetrosis |
unaffected |
unaffected |
elevated |
unaffected |
thick dense bones also known as marble bone |
Osteomalacia and rickets |
decreased |
decreased |
elevated |
elevated |
soft bones |
Osteitis fibrosa cystica |
elevated |
decreased |
elevated |
elevated |
brown tumors |
Paget's disease of bone |
unaffected |
unaffected |
variable (depending on stage of disease) |
unaffected |
abnormal bone architecture |
Variations
The several forms are:
Name |
OMIM |
Gene |
OPTA1 |
607634 |
LRP5 |
OPTA2 |
166600 |
CLCN7 |
OPTB1 |
259700 |
TCIRG1 |
OPTB2 |
259710 |
TNFSF11 |
OPTB3 |
259730 |
CA2 (renal tubular acidosis) |
OPTB4 |
611490 |
CLCN7 |
OPTB5 |
259720 |
OSTM1 |
OPTB6 |
611497 |
PLEKHM1 |
OPTB7 |
612301 |
TNFRSF11A |
Differential diagnosis
The differential diagnoses include other disorders which can cause diffuse osteosclerosis, such as hypervitaminosis D and hypoparathyroidism, Paget's disease, diffuse bone metastasis of breast or prostate cancer (which tend to be osteoblastic, while most metastases are osteolytic), intoxication with fluoride, lead or beryllium, and hematological disorders such as myelofibrosis, sickle cell disease, and leukemia.
Treatment
The only durable cure for osteopetrosis types affecting the osteoclasts (most types) is bone marrow transplant.[6]
If complications occur in children, patients can be treated with vitamin D. Gamma interferon has also been shown to be effective, and it can be associated to vitamin D. Erythropoetin has been used to treat any associated anemia. Corticosteroids may alleviate both the anemia and stimulate bone resorption. Fractures and osteomyelitis can be treated as usual.
Notable cases
- Laurel Burch[7]
- Lil Bub[8]
See also
References
- ^ "Marble Bone Disease: A Review of Osteopetrosis and Its Oral Health Implications for Dentists". Cda-adc.ca. Retrieved 2013-10-17.
- ^ Lam DK, Sándor GK, Holmes HI, Carmichael RP, Clokie CM (2007). "Marble bone disease: a review of osteopetrosis and its oral health implications for dentists". J Can Dent Assoc 73 (9): 839–43. PMID 18028760.
- ^ Horvai, Andrew (2012). Bone and Soft Tissue Pathology (in English). Elsevier Health Sciences. p. 17. ISBN 9781437725209. Retrieved 31 August 2014.
- ^ Robbins Basic Pathology by Kumar, Abbas, Fausto, and Mitchell, 8th edition
- ^ Robins basic pathology
- ^ Tolar J, Teitelbaum S, Orchard PJ (2004). "Osteopetrosis". New England Journal of Medicine 351 (27): 2839–49. doi:10.1056/NEJMra040952. PMID 15625335.
- ^ Maddan, Heather (2007-09-23). "Marin County artist Laurel Burch dead at 61 of rare bone disease". The San Francisco Chronicle. Retrieved 2007-12-23.
- ^ "The Story of Lil BUB". YouTube. Retrieved 2013-10-17.
External links
- Osteopetrosis - Pediatric Blood and Marrow Transplantation Center at University of Minnesota Masonic Children's Hospital[1]
- GeneReviews/NCBI/NIH/UW entry on CLCN7-Related Osteopetrosis
- Rarediseases.org
Osteochondrodysplasia (Q77–Q78, 756.4–756.5)
|
|
Osteodysplasia//
osteodystrophy |
Diaphysis |
- Camurati–Engelmann disease
|
|
Metaphysis |
- Metaphyseal dysplasia
- Jansen's metaphyseal chondrodysplasia
- Schmid metaphyseal chondrodysplasia
|
|
Epiphysis |
- Spondyloepiphyseal dysplasia congenita
- Multiple epiphyseal dysplasia
- Otospondylomegaepiphyseal dysplasia
|
|
Osteosclerosis |
- Raine syndrome
- Osteopoikilosis
- Osteopetrosis
|
|
Other/ungrouped |
- FLNB
- Opsismodysplasia
- Polyostotic fibrous dysplasia
|
|
|
Chondrodysplasia/
chondrodystrophy
(including dwarfism) |
Osteochondroma |
- osteochondromatosis
- Hereditary multiple exostoses
|
|
Chondroma/enchondroma |
- enchondromatosis
- Ollier disease
- Maffucci syndrome
|
|
Growth factor receptor |
FGFR2: |
|
|
FGFR3: |
- Achondroplasia
- Thanatophoric dysplasia
|
|
|
COL2A1 collagen disease |
- Achondrogenesis
- Hypochondrogenesis
|
|
SLC26A2 sulfation defect |
- Achondrogenesis
- Autosomal recessive multiple epiphyseal dysplasia
- Atelosteogenesis, type II
- Diastrophic dysplasia
|
|
Chondrodysplasia punctata |
- Rhizomelic chondrodysplasia punctata
- Conradi–Hünermann syndrome
|
|
Other dwarfism |
- Fibrochondrogenesis
- Short rib – polydactyly syndrome
- Majewski's polydactyly syndrome
- Léri–Weill dyschondrosteosis
|
|
|
|
anat (c/f/k/f, u, t/p, l)/phys/devp/cell
|
noco/cong/tumr, sysi/epon, injr
|
|
|
|
|
Genetic disorder, membrane: cell surface receptor deficiencies
|
|
G protein-coupled receptor
(including hormone) |
Class A |
- TSHR (Congenital hypothyroidism 1)
- LHCGR (Male-limited precocious puberty)
- FSHR (XX gonadal dysgenesis)
- EDNRB (ABCD syndrome, Waardenburg syndrome 4a, Hirschsprung's disease 2)
- AVPR2 (Nephrogenic diabetes insipidus 1)
- PTGER2 (Aspirin-induced asthma)
|
|
Class B |
- PTH1R (Jansen's metaphyseal chondrodysplasia)
|
|
Class C |
- CASR (Familial hypocalciuric hypercalcemia)
|
|
Class F |
- FZD4 (Familial exudative vitreoretinopathy 1)
|
|
|
Enzyme-linked receptor
(including
growth factor) |
RTK |
- ROR2 (Robinow syndrome)
- FGFR1 (Pfeiffer syndrome, KAL2 Kallmann syndrome)
- FGFR2 (Apert syndrome, Antley–Bixler syndrome, Pfeiffer syndrome, Crouzon syndrome, Jackson–Weiss syndrome)
- FGFR3 (Achondroplasia, Hypochondroplasia, Thanatophoric dysplasia, Muenke syndrome)
- INSR (Donohue syndrome
- Rabson–Mendenhall syndrome)
- NTRK1 (Congenital insensitivity to pain with anhidrosis)
- KIT (KIT Piebaldism, Gastrointestinal stromal tumor)
|
|
STPK |
- AMHR2 (Persistent Müllerian duct syndrome II)
- TGF beta receptors: Endoglin/Alk-1/SMAD4 (Hereditary hemorrhagic telangiectasia)
- TGFBR1/TGFBR2 (Loeys-Dietz syndrome)
|
|
GC |
- GUCY2D (Leber's congenital amaurosis 1)
|
|
|
JAK-STAT |
- Type I cytokine receptor: GH (Laron syndrome)
- CSF2RA (Surfactant metabolism dysfunction 4)
- MPL (Congenital amegakaryocytic thrombocytopenia)
|
|
TNF receptor |
- TNFRSF1A (TNF receptor associated periodic syndrome)
- TNFRSF13B (Selective immunoglobulin A deficiency 2)
- TNFRSF5 (Hyper-IgM syndrome type 3)
- TNFRSF13C (CVID4)
- TNFRSF13B (CVID2)
- TNFRSF6 (Autoimmune lymphoproliferative syndrome 1A)
|
|
Lipid receptor |
- LRP: LRP2 (Donnai–Barrow syndrome)
- LRP4 (Cenani–Lenz syndactylism)
- LRP5 (Worth syndrome, Familial exudative vitreoretinopathy 4, Osteopetrosis 1)
- LDLR (LDLR Familial hypercholesterolemia)
|
|
Other/ungrouped |
- Immunoglobulin superfamily: AGM3, 6
- Integrin: LAD1
- Glanzmann's thrombasthenia
- Junctional epidermolysis bullosa with pyloric atresia
EDAR (EDAR Hypohidrotic ectodermal dysplasia)
- PTCH1 (Nevoid basal cell carcinoma syndrome)
- BMPR1A (BMPR1A Juvenile polyposis syndrome)
- IL2RG (X-linked severe combined immunodeficiency)
|
|
- See also
- cell surface receptors
- B structural
- perx
- skel
- cili
- mito
- nucl
- sclr
- DNA/RNA/protein synthesis
- membrane
- transduction
- trfk
|
|
Genetic disorder, membrane: ATPase disorders
|
|
ATP1 |
- ATP1A2 (Alternating hemiplegia of childhood)
|
|
ATP2 |
- ATP2A1 (Brody myopathy)
- ATP2A2 (Darier's disease, Acrokeratosis verruciformis)
- ATP2C1 (Hailey–Hailey disease)
|
|
ATP7 |
- ATP7A (Menkes disease)
- ATP7B (Wilson's disease)
|
|
ATP13 |
- ATP13A2 (Kufor–Rakeb syndrome)
|
|
Other |
|
|
see also ATPase
- B structural
- perx
- skel
- cili
- mito
- nucl
- sclr
- DNA/RNA/protein synthesis
- membrane
- transduction
- trfk
|
|
- ^ "About University of Minnesota Masonic". www.uofmchildrenshospital.org. Retrieved 5 November 2014.